About this trial

The development of neuropathic pain is one of the most debilitating sequels after a spinal cord injury (SCI). The overall aim of this study is to investigate potential underlying pathophysiological mechanisms of neuropathic pain after SCI. The functionality of the nociceptive pathway in humans as well as its plastic changes following SCI will be inferred with sophisticated sensory and pain phenotyping using quantitative sensory testing (i.e., psychophysical measures), objective neurophysiological measures of pain processing and the recording of pain-related autonomic responses (i.e., galvanic skin response, cardiovascular measures and pupil dilation). In addition, the interplay between the somatosensory and autonomic nervous system and its association with the development and maintenance of neuropathic pain after SCI will be investigated.

Eligibility criteria

Qualifiers

Aged between 18-80 years

Traumatic and non-traumatic etiology

Para- and tetraplegic SCI

Complete and incomplete SCI

Disqualifiers

Inability to follow study instructions

Pregnancy

Medically manifested psychological disorder

Medical condition affecting the peripheral and/or central nervous system other than the desired experimental condition (e.g., additional peripheral neuropathy in the SCI cohort)

Trial design

Treatments tested in this trial

  • Neurophysiology
  • Cardiovascular test
  • Experimental pain paradigms
  • Quantitative sensory testing
  • Clinical pain phenotype
  • Pupillometry

Treatment groups

300 Participants
are divided into 4 treatment groups

Locations

1
Balgrist University Hospital8008, ZurichCanton of Zurich, Switzerland

Sponsors and collaborators

University of Zurich

Lead sponsor

Swiss National Science Foundation

Collaborator